| Literature DB >> 21365188 |
James Welsh1, Arya Amini, Anna Likhacheva, Jeremy Erasmus J, Daniel Gomez, Marta Davila, Reza J Mehran, Ritsuko Komaki, Zhongxing Liao, Wayne L Hofstetter, Jeffrey Lee H, Manoop S Bhutani, Jaffer A Ajani.
Abstract
The optimal treatment strategy for esophageal cancer continues to be a topic of debate. Improvements in chemotherapy drugs, surgical techniques, and radiotherapy planning and delivery have led to the design of treatment approaches that are specific to both the stage of the tumor and the overall performance status of the patient. Surgery continues to be the standard treatment option for localized disease, but multimodality treatments that include radiation and chemotherapy with surgery are increasingly used. The next few years will continue to see improvements in radiation techniques, especially proton beam treatment; the development of additional minimally invasive surgical approaches to minimize postoperative side effects; and the discovery of molecular biomarkers to help specifically target treatment of esophageal cancer in individual patients.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21365188 PMCID: PMC4086148 DOI: 10.1007/s11912-011-0158-z
Source DB: PubMed Journal: Curr Oncol Rep ISSN: 1523-3790 Impact factor: 5.075